H1FX (C-term), 138-167 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-H1FX (C-term), 138-167 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityH1FX (C-term), 138-167
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman
Isotypen/a
Formatpeptide affinity purified
Size0.08 mL, 0.4 mL
Concentrationvial concentration: 0.5
ApplicationsWestern Blot (WB), ELISA (EIA)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThis H1FX antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 138-167 amino acids from the C-terminal region of human H1FX. Histones are basic nuclear proteins that are responsiblefor the nucleosome structure of the chromosomal fiber ineukaryotes. Nucleosomes consist of approximately 146 bp of DNAwrapped around a histone octamer composed of pairs of each of thefour core histones (H2A, H2B, H3, and H4). The chromatin fiber isfurther compacted through the interaction of a linker histone, H1,with the DNA between the nucleosomes to form higher order chromatinstructures. This gene encodes a member of the histone H1 family.
Immunogenn/a
Other Names[Histone H1x; H1FX]
Gene, Accession #[H1FX], Gene ID: 8971, NCBI: NP_006017.1, UniProt: Q92522
Catalog #MBS9210884
Price$165, $370
Order / More InfoH1FX (C-term), 138-167 Antibody from MYBIOSOURCE INC.
Product Specific ReferencesWarneboldt, J., et al. BMC Cancer 8, 388 (2008) : Stoldt, S., et al. Biol. Cell 99(10):541-552(2007) Takata, H., et al. FEBS Lett. 581(20):3783-3788(2007) Sugiyama, N., et al. Mol. Cell Proteomics 6(6):1103-1109(2007) Olsen, J.V., et al. Cell 127(3):635-648(2006)
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.